Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

Stroke

Volumn 27, Issue 9, 1996, Pages 1711-1718

  Adams Jr , Harold P ^a   Brott, Thomas G ^a   Furlan, Anthony J ^a   Gomez, Camilo R ^a   Grotta, James ^a   Helgason, Cathy M ^a   Kwiatkowski, Thomas ^a   Lyden, Patrick D ^a   Marier, John R ^a   Torner, James ^a   Feinberg, William ^a   Mayberg, Marc ^a   Thies, William ^a  

^a NONE

Author keywords

ischemia; plasminogen; streptokinase; stroke; thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; PLACEBO; PLASMINOGEN[LYSINE]; SARUPLASE; STREPTOKINASE; TICLOPIDINE; WARFARIN;

BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECANALIZATION; REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN ISCHEMIA; HUMANS; THROMBOLYTIC THERAPY; UNITED STATES;

EID: 9544220640     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Marier JR, Woolson RF, Zivin JA, Feinberg W, Mayberg M. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:1901-1914.
2. Hommel M, Boissel JP, Cornu C, Boutitie F, Lees KR, Besson G, Leys D, Amarenco P, Bogaert M, for the MAST Study Group. Termination of trial of streptokinase in severe acute ischaemic stroke. Lancet. 1994;345:57. Letter.
3. Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EG, Tuck RR. Trials of streptokinase in severe acute ischaemic stroke. Lancet. 1995;345:578-579.
4. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M, for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995; 274:1017-1025.
5. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346:1509-1514.
6. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
7. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102(suppl 4):305S-311S.
8. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Neurology. 1963;13:927-937.
9. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA. 1964;189:373.
10. Fletcher AP, Alkjaersig N, Lewis N, Tulevski V, Davies A, Brooks JE, Hardin WB, Landau WM, Raichle ME. A pilot study of urokinase therapy in cerebral infarction. Stroke. 1976;7:135-142.
11. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
12. Wardlaw JM, Warlow CP. Thrombolysis in acute ischemic stroke: does it work? Stroke. 1992;23:1826-1839.
13. Nenci GG, Gresele P, Taramelli M, Agnelli G. Signorini E. Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology. 1983;34:561-571.
14. Zeumer H, Hundgen R, Herbert A, Ringelstein EB. Local intra-arterial fibrinolytic therapy in inaccessible internal carotid occlusion. Neuroradiology. 1984;26:315-317.
15. Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988;19:802-812.
16. del Zoppo GJ, Ferbert A, Otis S, Bruckmann H, Hacke W, Zyroff J, Harker LA, Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke. 1988;19:307-313.
17. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ. Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988;19:1216-1222.
18. Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganem F, Maiza D. Local intra-arterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol. 1989;10:753-765.
19. Castro L, Moschini L, Camerlingo M, Gazzaniga G, Partziguain T, Belloni G, Mamoli A. Local intraarterial thrombolysis for acute stroke in the carotid artery territories. Acta Neurol Scand. 1992; 86:308-311.
20. Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis. 1992;34:235-262.
21. von Kummer R, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke. 1992;23:646-652.
22. Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992;42:976-982.
23. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Granlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32:78-86.
24. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marier JR. Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23:632-640.
25. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MC, Kongable G, Torner JC, Marier JR. Urgent therapy for stroke, II: pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke. 1992;23:641-645.
26. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ, the rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 1993;14:3-13.
27. Zeumer H, Freitag HJ, Zanella F, Thie A, Arning C. Local intraarterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology. 1993;35:159-162.
28. Yamaguchi T (for the Japanese Thrombolysis Study Group). Intravenous tissue plasminogen activator in acute thromboembolic stroke: a placebo-controlled, double blind trial. In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg, Germany: Springer-Verlag; 1993.
29. Haley EC Jr, Brott TG, Sheppard GL, Barsan W, Broderick J, Marier JR, Kongable GL, Spilker J, Massey S, Hansen CA, Torner JC, for the TPA Bridging Study Group. Pilot randomized trial of tissue plasminogen activator for acute ischemic stroke. Stroke. 1993;24:1000-1004.
30. Schumacher M, Siekmann R, Randu W, Wakhloo AK. Local intraarterial fibrinolytic therapy in vertebrobasilar occlusion. In: Bauer BL, Brock M, Klinger M, eds. Advances in Neurosurgery. Berlin, Germany: Springer-Verlag; 1994:22:30-34.
31. Freitag HJ, Becker A, Thie A, Tilsner V, Philapitsch A, Scharz HP, Webhof U, Muller A, Zeumer H. Plasminogen plus rtPA improves intra-arterial thrombolytic therapy in acute ischemic stroke. In: Yamaguchi T, Mori E, Minematsu K, del Zoppo GJ, eds. Thrombolytic Therapy in Acute Ischemic Stroke III. Tokyo, Japan: Springer-Verlag; 1995:271-278.
32. Matsumoto K, Satoh K. Intra-arterial therapy in acute ischemic stroke. In: Yamaguchi T, Mori E, Minematsu K, del Zoppo GL, eds. Thrombolytic Therapy in Acute Ischemic Stroke III. Tokyo, Japan: Springer-Verlag; 1995.
33. Gotoh K, Ogata N. 'Central' intraarterial thrombolysis using a newly developed low friction guidewire/catheter system. In: Yamaguchi T, Mori E, Minematsu K, del Zoppo GJ, eds. Thrombolytic Therapy in Acute Ischemic Stroke III. Tokyo, Japan: Springer-Verlag; 1995.
34. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intraarterial local approaches. Neurosurgery. 1995;36:246-253.
35. Barr JD, Horowitz MB, Mathis JM, Sclabassi RJ, Yonas H. Intraoperative urokinase infusion for embolic stroke during carotid endarterectomy. Neurosurgery. 1995;36:606-611.
36. Huemer M, Niederwieser V, Ladurner G. Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiatry. 1995;58:227-228.
37. Frey JL, Greene KA, Khayata MH, Dean BL, Hodak JA, Spetzler RF. Intrathrombus administration of tissue plasminogen activator in acute cerebrovascular occlusion. Angiology. 1995;46:649-656.
38. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Gent M, Driscoll RM, and the PROACT Investigators. The Prolyse in Acute Cerebral Thromboembolism Trial (PROACT): results of 6 mg dose tier. Stroke. 1996;27:164. Abstract.
39. Nesbit GM, Clark WM, O'Neill OR, Barnwell SL. Intracranial intraarterial thrombolysis facilitated by microcatheter navigation through an occluded cervical internal carotid artery. J Neurosurg. 1996; 84:387-392.
40. The EMS Bridging Trial Investigators. Combined intravenous/intraarterial thrombolytic therapy: safety, time-to-treatment, and frequency of clot. Stroke. 1996;27:165. Abstract.
41. Ferguson RD, Ferguson JG. Cerebral intra-arterial fibrinolysis at the crossroads: is a phase III trial advisable at this time? AJNR Am J Neuroradiol. 1994;15:1201-1216.
42. del Zoppo GJ, Higashida RT, Furlan AJ. The case for a phase III trial of cerebral intraarterial fibrinolysis. AJNR Am J Neuroradiol. 1994;15:1217-1222.
43. Tomsick T, Brott T, Barsan W, Broderick J. Haley EC, Spilkler J, Khovry J. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol. 1996;17:79-85.
44. Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, Babb J, Herman M, Roberts WC, Spoko G, Bovill E, Forman S, Knatterud GL, for the TIMI Investigators. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the TIMI II pilot and randomized clinical trial combined experience. Neurology. 1995;45:649-658.
45. Simoons ML, Maggioni AP, Knattemd G, Leimberger JD, de Jaegere P, van Domburg R, Boersma E. Franzosi MG, Califf R, Schroder R, Braunwald E. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993;342:1523-1528.
46. Marder VJ, Sherry S. Thrombolytic therapy: current status. N Engl J Med. 1988;318:1512-1520, 1585-1595.
47. Anderson JL, Karagounis L, Allen A, Bradford MJ, Menlove RL, Pryor TA. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol. 1991;68:166-170.
48. Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML, and the TIMI Investigators. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study: Thrombolysis in Myocardial Infarction Phase II, pilot and clinical trial. Criculation. 1991;83:448-459.
49. Gunnar RM, Bourdillon PD, Dixon DW, Fuster V, Karp RB, Kennedy JW, Klocke FJ, Passamani ER, Pitt B, Rapaport E, Reeves TJ, Russell RO Jr, Sobel BE, Winters WL Jr. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. Circulation. 1990;82:664-707.
50. Levy DE, Brott TG, Haley EC Jr, Marier JR, Sheppard GL, Barsan W, Broderick JP. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke. 1994;25:291-297.
51. Leaker M, Nitschmann E, Mitchell L, Andrew M. Thrombolytic therapy in pediatric patients. Thromb Haemost. 1995;73:948.
52. Nicolini FA, Lee P, Rios P, Rios G, Kottke-Marchant K, Topol EJ. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improved thrombolysis. Circulation. 1994;89:1802-1809.
53. del Zoppo GJ. Acute stroke: on the threshold of a therapy? N Engl J Med. 1995;333:1632-1633.
54. Sherman DG, Dyken ML Jr, Gent M, Harrison JG, Hart RG, Mohr JP. Antithrombotic therapy for cerebrovascular disorders: an update. Chest. 1995;108(suppl):444S-456S.